1
|
Yunrong W, Xinrong W, Wenqi S, Bei Z, Yifan L, Weiwei W, Muhan N, Lei W, Min C. Compound traditional serrated adenoma and superficially serrated adenoma: a lesion of the rectum. Gastrointest Endosc 2024; 99:654-656. [PMID: 37806404 DOI: 10.1016/j.gie.2023.10.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/05/2022] [Revised: 12/29/2022] [Accepted: 10/03/2023] [Indexed: 10/10/2023]
Affiliation(s)
- Wang Yunrong
- Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China
| | - Wu Xinrong
- Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China
| | - Sun Wenqi
- Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China
| | - Zhao Bei
- Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China
| | - Li Yifan
- Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China
| | - Wang Weiwei
- Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China
| | - Ni Muhan
- Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China
| | - Wang Lei
- Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China
| | - Chen Min
- Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China
| |
Collapse
|
2
|
Wenqi S, Bei Z, Yunrong W, Xinrong W, Yifan L, Weiwei W, Muhan N, Peng Y, Xiaotan D, Wen L, Hua Y, Lei W, Min C. Lactulose vs Polyethylene Glycol for Bowel Preparation: A Single-Center, Prospective, Randomized Controlled Study Based on BMI. Clin Transl Gastroenterol 2024; 15:e00652. [PMID: 37795904 PMCID: PMC10810567 DOI: 10.14309/ctg.0000000000000652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Accepted: 09/29/2023] [Indexed: 10/06/2023] Open
Abstract
INTRODUCTION Colonoscopy is currently considered as one of the principal techniques to diagnose the colorectal diseases. Admittedly, qualified bowel preparation before colonoscopy is a premise for high-quality examination. Lower quality bowel preparation might seriously impede visualization of the intestinal mucosa, resulting in missed and misdiagnosed intestinal lesions. Therefore, it is necessary to choose the appropriate oral laxative based on the guarantee of safety and efficacy. METHODS This prospective randomized controlled study was conducted to compare lactulose oral solution and polyethylene glycol (PEG) electrolyte powder for bowel preparation using the following indicators: Boston Bowel Preparation Scale, Bowel Bubble Score, detection rate of adenoma and lesion, patients' satisfaction, and adverse effects. Our study investigated the suitability of 2 bowel preparation reagents for patients with different body mass indices mainly based on body mass index (BMI). RESULTS In the lactulose group, there was a significant improvement in the quality of bowel preparation compared with those in the PEG group ( P < 0.05), especially in people with normal BMI and higher BMI. Compared with the PEG group, individuals in the lactulose group had a significantly higher adenoma detection rate (50% vs 33.5%, P < 0.05) and taste scores (8.82 vs 6.69, P < 0.05), as well as significantly fewer adverse reactions (6.5% vs 32.5%, P < 0.05). DISCUSSION Lactulose oral solution is superior to PEG in bowel preparation quality and taste, especially in normal BMI and higher BMI groups. It can be used clinically as a potential and promising bowel preparation agent in the future. Clinical Trial registration number: ChiCTR2100054318.
Collapse
Affiliation(s)
- Sun Wenqi
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Zhao Bei
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Wang Yunrong
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Wu Xinrong
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Li Yifan
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Wang Weiwei
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Ni Muhan
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Yan Peng
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Dou Xiaotan
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Li Wen
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Yang Hua
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Wang Lei
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| | - Chen Min
- Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing City, P.R. China.
| |
Collapse
|
3
|
Jiaqi L, Siqing H, Qin W, di Z, Bei Z, Jialin Y. Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction. Phytomedicine 2023; 109:154601. [PMID: 36610134 DOI: 10.1016/j.phymed.2022.154601] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Revised: 11/22/2022] [Accepted: 12/10/2022] [Indexed: 06/17/2023]
Abstract
BACKGROUND Ferroptosis, a form of regulated cell death by lipid peroxidation, was currently considered as a key factor affecting the occurrence and progression in various cancers. Andrographolide (ADE), a major effective ingredient of Andrographis paniculate, has proven to have a substantial anti-tumor effect on multiple cancer types. However, the function and underlying mechanism of ADE in Non-Small Cell Lung Cancer remain unclear. METHODS CCK8 assay, colony-formation assay, flow cytometry, scratch test, transwell assay, western blotting, ferroptosis analysis and mitochondria analysis were performed to reveal the role and underlying mechanisms of ADE in NSCLC cell lines (H460 and H1650). In vivo, xenograft model and lung metastatic model were performed to verify the effect of ADE on the growth and metastasis of NSCLC. RESULTS In this present study, we demonstrated that treatment with ADE could inhibit cell growth and metastases through eliciting ferroptosis in vitro an in vivo. The IC50 of ADE in H460 and H1650 cells were 33.16 μM and 32.45 μM respectively. In Lewis xenografted animals, i.p. ADE repressed relative tumor growth (p < 0.01) and inhibited metastases (p < 0.01). Notably, the ferroptosis inhibitor Fer-1 abrogated the anti-tumor capacity of ADE. Induction of ferroptosis by ADE was confirmed by elevated levels of reactive oxygen sepsis (ROS), glutathione (GSH), malondialdehyde (MDA), intracellular iron content and lipid ROS reduced glutathione (GSH) accumulation (p < 0.01). Furthermore, ADE inhibited the expression of ferroptosis-related protein GPX4 and SLC7A11. Simultaneously, it also disclosed that ADE enhanced mitochondrial dysfunction, as evidenced by increased mitochondrial ROS release, mitochondrial membrane potential (MMP) depolarization, and decreased mitochondrial ATP. Most interestingly, Mito-TEMPO, a mitochondria-targeted antioxidant, rescued ADE-induced ferroptosis. CONCLUSION Our data validated that ADE treatment could restrain proliferation and metastases of NSCLC cells through induction of ferroptosis via potentiating mitochondrial dysfunction.
Collapse
Affiliation(s)
- Li Jiaqi
- Department of Oncology, Yue yang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200080, China
| | - Huang Siqing
- Department of Oncology, Yue yang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200080, China
| | - Wang Qin
- Department of Oncology, Yue yang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200080, China
| | - Zhou di
- Department of Oncology, Yue yang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200080, China
| | - Zhao Bei
- China Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
| | - Yao Jialin
- Department of Oncology, Yue yang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200080, China.
| |
Collapse
|
6
|
Liu Y, Li T, Deng Y, Liu S, Zhang D, Li H, Wang X, Jia L, Han J, Bei Z, Li L, Li J. Stability of SARS-CoV-2 on environmental surfaces and in human excreta. J Hosp Infect 2020; 107:105-107. [PMID: 33137445 PMCID: PMC7603996 DOI: 10.1016/j.jhin.2020.10.021] [Citation(s) in RCA: 80] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Revised: 10/19/2020] [Accepted: 10/21/2020] [Indexed: 01/22/2023]
Affiliation(s)
- Y Liu
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - T Li
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Y Deng
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - S Liu
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - D Zhang
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - H Li
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - X Wang
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - L Jia
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - J Han
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Z Bei
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - L Li
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China.
| | - J Li
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, People's Republic of China.
| |
Collapse
|
7
|
Yu B, Zhao S, Hu D, Ambegaonakr BM, DYSIS-China Study Investigators, Jia Er BA, Guiwen C, Buxing C, Hong C, Jin C, Jing C, Liefeng C, Min C, Qiong C, Shaoliang C, Tielong C, Xiaofei C, Xiaohong C, You C, Guoli C, Mei C, Hongliang C, Qin C, Shiwei C, Yong C, Shudong D, Henghua D, Xiaomei D, Yirong D, Xiaoyan D, Birong D, Yumei D, Yugang D, Ping D, Lei D, Limei F, Ningyuan F, Lixia F, Lie F, Jun G, GeWeihong, Hongmin G, Minxia G, Qinghua H, Fengchang H, Dayi H, Lingzhi H, Xueqiang H, Yaojun H, Yiming H, Zhiping H, Fei H, Qi H, Dejia H, Gewen H, Hongman H, Liming H, Qiong H, Ruowen H, Taifu H, Bin J, Kai J, Hui J, Huigen J, Jinsong K, Bao L, Chengjiang L, Hongjuan L, Jun(Xinjiang) L, Jun(Jiangsu) L, Nanfang L, Qifu L, Qiang L, Xin L, Xueyou L, Yanbing L, Yanping L, Yansheng L, Yong L, Yuling L, Zhanquan L, Zhengfang L, Li L, Yongxue L, Zerong L, Yuhua L, Fan L, Hong L, Hui L, Minling L, Qiang L, Qingsong L, Shaokui L, Weidong L, Xueping L, Xinjian L, Benyan L, Shaonian L, Suxin L, Hong L, LvYun, Aiqun M, Jianhua M, Qiang M, Yan M, Changsheng M, Yide M, Yiming M, NieXiaoli, NiuXiaoyuan, Hongtao P, Mingkang P, Qiaoqing P, Huifen Q, Qiumin Q, Lijie Q, Liqun R, Jingshan S, Qiang S, Jing H, Xiuyun S, Yongquan S, Liangyi S, Zhi S, Zhiyuan S, Yufeng S, Chunyan T, TengXiaochun, Haoming T, Wenhua T, Qinwei T, TuQiuyun, Keying W, Aihong W, Chaohui W, Chunning W, Dezhao W, Guixia W, Hanqiao W, Jianan W, Jianjun W, Lan W, Xiaoming W, Yaping W, Yangwei W, Yongjun W, Meifang W, Yidong W, Hongyun W, Chun W, Dongmei W, Jiang W, Jun W, Xiaolin W, Zonggui W, XiGuangxia, Yi X, Qian X, Xiaoping X, Yulong X, Anding X, XueYuanming, Chuanzhu Y, Tao Y, Xiaowei Y, Gangyi Y, Jian Y, Wangpingm Y, Xiaosu Y, Xinchun Y, Yifang Y, Yu Y, Mingyu Y, Min Y, Ping Y, Bo Y, Jiangyi Y, Jinming Y, Yan Y, Ling Z, Longyi Z, Xiaoyun Z, Baorong Z, Bei Z, Chaoxin Z, Xuelian Z, Dadong Z, Dongping Z, Fuchun Z, Hong Z, Huifang Z, Liping Z, Liyang Z, Rufu Z, Saidan Z, Weijuan Z, Dong Z, Gang Z, Shuiping Z, Xiuxin Z, Qiangsun Z, Yang Z, Xiaohui Z, Yali Z, Yujie Z, Yi Z, Yulan Z, Xiangping Z. Gender differences in lipid goal attainment among Chinese patients with coronary heart disease: insights from the DYSlipidemia International Study of China. Eur Heart J Suppl 2015. [DOI: 10.1093/eurheartj/suv018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|